Stay fully informed. Get the latest news from Brooklyn ImmunoTherapeutics.

April 15, 2022

Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results

March 9, 2022

Brooklyn ImmunoTherapeurics Announces Closing of $12 Million Private Placement

March 7, 2022

Brooklyn ImmunoTherapeutics Announces $12 Million Private Placement

January 20, 2022

Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

January 13, 2022

Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio

December 17, 2021

Brooklyn ImmunoTherapeutics Added to ICE Biotechnology Index

December 14, 2021

Brooklyn ImmunoTherapeutics Named to Nasdaq Biotechnology Index

December 2, 2021

Brooklyn ImmunoTherapeutics to Present at Two Upcoming December Conferences

November 29, 2021

Brooklyn ImmunoTherapeutics Welcomes Susan McClatchey as Vice President and Head of Quality

October 14, 2021

Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq